AH Equity Partners Bio II, L.L.C. Q4 2021 holdings

$192 Million is the total value of AH Equity Partners Bio II, L.L.C.'s 4 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .

 Value Shares↓ Weighting
NewEQRx, Inc.$118,93017,438,465
+100.0%
61.93%
NewErasca, Inc.$38,9502,500,000
+100.0%
20.28%
NVTA NewInVitae Corporation$17,8681,170,127
+100.0%
9.30%
NAUT NewNautilus Biotechnology, Inc.$16,29816,298,006
+100.0%
8.49%
Signed by
  • Scott Kupor — Chief Operating Officer